Neon drop · Free ship $75+ · Enter the grid
Login Register
Signal · Product Feed
AZD5363 Catalog No.:M10096-10 402(2-3):121-3
AZD5363 Catalog No.:M10096-10 402(2-3):121-3
AZD5363 Catalog No.:M10096-10 402(2-3):121-3
AZD5363 Catalog No.:M10096-10 402(2-3):121-3

AZD5363 Catalog No.:M10096-10 402(2-3):121-3

SKU: 11238952465

4.9
USD85.00 USD132.00

Pay in 4 interest-free payments of $21.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Live Spec

AZD5363 Catalog No.:M10096-10 402(2-3):121-3AZD5363, also known as Capivasertib, is an orally available inhibitor of the serine threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor AZD5363 binds to and inhibits all AKT isoforms. Inhibition of AKT prevents the phosphorylation of AKT substrates that mediate cellular processes, such as cell division, apoptosis, and glucose and fatty acid metabolism. A wide range of solid and hematological

Store: avramcheva.com · Domain: avramcheva.com

Description

402(2-3):121-3

Minakuchi K

Formula: C25H29FN4O5

RPR 102341 is structurally similar to the fluoroquinolone class of antibiotics

NSC-664704

AZD5363 Catalog No.:M10096-10 402(2-3):121-3AZD5363, also known as Capivasertib, is an orally available inhibitor of the serine threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor AZD5363 binds to and inhibits all AKT isoforms. Inhibition of AKT prevents the phosphorylation of AKT substrates that mediate cellular processes, such as cell division, apoptosis, and glucose and fatty acid metabolism. A wide range of solid and hematological

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products